Cargando…

The ischemic model of chronic muscle spasm and pain

This article was not intended to be a complete review of the electromyography of pathological muscle states, but it was written to illustrate how the “Coletti Method of EMG ChemoDenervation” (CMECD(©)) protocol for the treatment of chronic pain resulting from chronic muscle spasm was developed and e...

Descripción completa

Detalles Bibliográficos
Autor principal: Coletti, Roger H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992665/
https://www.ncbi.nlm.nih.gov/pubmed/35044134
http://dx.doi.org/10.4081/ejtm.2022.10323
_version_ 1784683776066977792
author Coletti, Roger H.
author_facet Coletti, Roger H.
author_sort Coletti, Roger H.
collection PubMed
description This article was not intended to be a complete review of the electromyography of pathological muscle states, but it was written to illustrate how the “Coletti Method of EMG ChemoDenervation” (CMECD(©)) protocol for the treatment of chronic pain resulting from chronic muscle spasm was developed and established. That process led to an unexpected understanding of the underlying pathophysiology of chronic muscle spasm, which represents a paradigm shift in our understanding and ultimately in our treatment of muscle spasm-induced chronic pain. Other investigators had brought to light the presence of spontaneous electrical activity (SEA) in states of muscle spasm. Those findings were all but ignored by standard EMG/Nerve conduction studies in clinical practice. Starting with a simple EMG device I experimented with various medications to treat patients with chronic pain associated with chronic muscle spasm. Suppression of SEA with long-acting medications resolved both the chronic spasm and chronic pain. A successful protocol using phenoxybenzamine was established and clinical outcomes were followed. More than 200 patients were successfully treated during last 12 years. Correlating known exercise muscle physiology with the development of the pathological state of chronic muscle spasm as seen by electromyography led to the postulation of the ischemic model of chronic muscle spasm. Light microscopy pathophysiologic supportive findings are presented and discussed. Predictions from this model to various aspects of treatment were supportive. Implications regarding treatment by the CMECD(©) procedure, as well as other standard therapies, are discussed. Application of the ischemic model to other pain conditions was explored with implications of therapeutic modification. Recommendations for changes in rehabilitation therapy are discussed.
format Online
Article
Text
id pubmed-8992665
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-89926652022-04-09 The ischemic model of chronic muscle spasm and pain Coletti, Roger H. Eur J Transl Myol Article This article was not intended to be a complete review of the electromyography of pathological muscle states, but it was written to illustrate how the “Coletti Method of EMG ChemoDenervation” (CMECD(©)) protocol for the treatment of chronic pain resulting from chronic muscle spasm was developed and established. That process led to an unexpected understanding of the underlying pathophysiology of chronic muscle spasm, which represents a paradigm shift in our understanding and ultimately in our treatment of muscle spasm-induced chronic pain. Other investigators had brought to light the presence of spontaneous electrical activity (SEA) in states of muscle spasm. Those findings were all but ignored by standard EMG/Nerve conduction studies in clinical practice. Starting with a simple EMG device I experimented with various medications to treat patients with chronic pain associated with chronic muscle spasm. Suppression of SEA with long-acting medications resolved both the chronic spasm and chronic pain. A successful protocol using phenoxybenzamine was established and clinical outcomes were followed. More than 200 patients were successfully treated during last 12 years. Correlating known exercise muscle physiology with the development of the pathological state of chronic muscle spasm as seen by electromyography led to the postulation of the ischemic model of chronic muscle spasm. Light microscopy pathophysiologic supportive findings are presented and discussed. Predictions from this model to various aspects of treatment were supportive. Implications regarding treatment by the CMECD(©) procedure, as well as other standard therapies, are discussed. Application of the ischemic model to other pain conditions was explored with implications of therapeutic modification. Recommendations for changes in rehabilitation therapy are discussed. PAGEPress Publications, Pavia, Italy 2022-01-18 /pmc/articles/PMC8992665/ /pubmed/35044134 http://dx.doi.org/10.4081/ejtm.2022.10323 Text en https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Coletti, Roger H.
The ischemic model of chronic muscle spasm and pain
title The ischemic model of chronic muscle spasm and pain
title_full The ischemic model of chronic muscle spasm and pain
title_fullStr The ischemic model of chronic muscle spasm and pain
title_full_unstemmed The ischemic model of chronic muscle spasm and pain
title_short The ischemic model of chronic muscle spasm and pain
title_sort ischemic model of chronic muscle spasm and pain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992665/
https://www.ncbi.nlm.nih.gov/pubmed/35044134
http://dx.doi.org/10.4081/ejtm.2022.10323
work_keys_str_mv AT colettirogerh theischemicmodelofchronicmusclespasmandpain
AT colettirogerh ischemicmodelofchronicmusclespasmandpain